Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Reviva Pharmaceuticals Q3 EPS $(0.44) Misses $(0.37) Estimate

Author: Benzinga Newsdesk | November 14, 2023 05:25pm
Reviva Pharmaceuticals (NASDAQ:RVPH) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.37) by 18.92 percent. This is a 144.44 percent decrease over losses of $(0.18) per share from the same period last year.

Posted In: RVPH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist